Viewing Study NCT01037205

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:13 AM

Ignite Modification Date: 2025-12-26 @ 1:52 AM

Study NCT ID: NCT01037205

Status: COMPLETED

Last Update Posted: 2014-04-08

First Post: 2009-12-18

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

Sponsor: Ansun Biopharma, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module